FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045803552> ?p ?o ?g. }

• W2045803552 endingPage "e3403" @default.
• W2045803552 startingPage "e3403" @default.
• W2045803552 abstract "Introduction Retail pharmaceutical products are commonly used to treat fever and malaria in sub-Saharan African countries. Small scale studies have suggested that poor quality antimalarials are widespread throughout the region, but nationwide data are not available that could lead to generalizable conclusions about the extent to which poor quality drugs are available in African communities. This study aimed to assess the quality of antimalarials available from retail outlets across mainland Tanzania. Methods and Findings We systematically purchased samples of oral antimalarial tablets from retail outlets across 21 districts in mainland Tanzania in 2005. A total of 1080 antimalarial formulations were collected including 679 antifol antimalarial samples (394 sulfadoxine/pyrimethamine and 285 sulfamethoxypyrazine/pyrimethamine), 260 amodiaquine samples, 63 quinine samples, and 51 artemisinin derivative samples. A systematic subsample of 304 products was assessed for quality by laboratory based analysis to determine the amount of the active ingredient and dissolution profile by following the published United States Pharmacopoeia (USP) monogram for the particular tablet being tested. Products for which a published analytical monogram did not exist were assessed on amount of active ingredient alone. Overall 38 or 12.2% of the samples were found to be of poor quality. Of the antifolate antimalarial drugs tested 13.4% were found to be of poor quality by dissolution and content analysis using high-performance liquid chromatography (HPLC). Nearly one quarter (23.8%) of quinine tablets did not comply within the tolerance limits of the dissolution and quantification analysis. Quality of amodiaquine drugs was relatively better but still unacceptable as 7.5% did not comply within the tolerance limits of the dissolution analysis. Formulations of the artemisinin derivatives all contained the stated amount of active ingredient when analysed using HPLC alone. Conclusions Substandard antimalarial formulations were widely available in Tanzania at the time of this study. No products were detected that did not contain any amount of the stated active ingredient. Quinine and sulfadoxine/pyrimethamine products were the most widely available and also the most likely to be of poor quality. Substandard products were identified in all parts of the country and were labeled as made by both domestic and international manufacturers. With the expansion of the retail pharmaceutical sector as a delivery channel for antimalarial formulations the need for regular nationwide monitoring of their quality will become increasingly important." @default.
• W2045803552 created "2016-06-24" @default.
• W2045803552 creator A5017212396 @default.
• W2045803552 creator A5021347036 @default.
• W2045803552 creator A5026823453 @default.
• W2045803552 creator A5077281219 @default.
• W2045803552 creator A5080121371 @default.
• W2045803552 creator A5084063981 @default.
• W2045803552 creator A5088841025 @default.
• W2045803552 date "2008-10-15" @default.
• W2045803552 modified "2023-10-02" @default.
• W2045803552 title "A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania" @default.
• W2045803552 cites W1524123901 @default.
• W2045803552 cites W1955275162 @default.
• W2045803552 cites W1998408776 @default.
• W2045803552 cites W2006740570 @default.
• W2045803552 cites W2050832165 @default.
• W2045803552 cites W2069802709 @default.
• W2045803552 cites W2073184516 @default.
• W2045803552 cites W2097260567 @default.
• W2045803552 cites W2104948735 @default.
• W2045803552 cites W2114035339 @default.
• W2045803552 cites W2142999550 @default.
• W2045803552 cites W2163483188 @default.
• W2045803552 cites W2164756514 @default.
• W2045803552 cites W3122758023 @default.
• W2045803552 doi "https://doi.org/10.1371/journal.pone.0003403" @default.
• W2045803552 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2565501" @default.
• W2045803552 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18923672" @default.
• W2045803552 hasPublicationYear "2008" @default.
• W2045803552 type Work @default.
• W2045803552 sameAs 2045803552 @default.
• W2045803552 citedByCount "63" @default.
• W2045803552 countsByYear W20458035522012 @default.
• W2045803552 countsByYear W20458035522013 @default.
• W2045803552 countsByYear W20458035522014 @default.
• W2045803552 countsByYear W20458035522015 @default.
• W2045803552 countsByYear W20458035522016 @default.
• W2045803552 countsByYear W20458035522017 @default.
• W2045803552 countsByYear W20458035522018 @default.
• W2045803552 countsByYear W20458035522019 @default.
• W2045803552 countsByYear W20458035522021 @default.
• W2045803552 countsByYear W20458035522022 @default.
• W2045803552 countsByYear W20458035522023 @default.
• W2045803552 crossrefType "journal-article" @default.
• W2045803552 hasAuthorship W2045803552A5017212396 @default.
• W2045803552 hasAuthorship W2045803552A5021347036 @default.
• W2045803552 hasAuthorship W2045803552A5026823453 @default.
• W2045803552 hasAuthorship W2045803552A5077281219 @default.
• W2045803552 hasAuthorship W2045803552A5080121371 @default.
• W2045803552 hasAuthorship W2045803552A5084063981 @default.
• W2045803552 hasAuthorship W2045803552A5088841025 @default.
• W2045803552 hasBestOaLocation W20458035521 @default.
• W2045803552 hasConcept C203014093 @default.
• W2045803552 hasConcept C205649164 @default.
• W2045803552 hasConcept C2776793103 @default.
• W2045803552 hasConcept C2776992834 @default.
• W2045803552 hasConcept C2777035104 @default.
• W2045803552 hasConcept C2777425658 @default.
• W2045803552 hasConcept C2777617192 @default.
• W2045803552 hasConcept C2778048844 @default.
• W2045803552 hasConcept C2779357621 @default.
• W2045803552 hasConcept C33070731 @default.
• W2045803552 hasConcept C556039675 @default.
• W2045803552 hasConcept C71924100 @default.
• W2045803552 hasConcept C86803240 @default.
• W2045803552 hasConcept C91375879 @default.
• W2045803552 hasConcept C99454951 @default.
• W2045803552 hasConceptScore W2045803552C203014093 @default.
• W2045803552 hasConceptScore W2045803552C205649164 @default.
• W2045803552 hasConceptScore W2045803552C2776793103 @default.
• W2045803552 hasConceptScore W2045803552C2776992834 @default.
• W2045803552 hasConceptScore W2045803552C2777035104 @default.
• W2045803552 hasConceptScore W2045803552C2777425658 @default.
• W2045803552 hasConceptScore W2045803552C2777617192 @default.
• W2045803552 hasConceptScore W2045803552C2778048844 @default.
• W2045803552 hasConceptScore W2045803552C2779357621 @default.
• W2045803552 hasConceptScore W2045803552C33070731 @default.
• W2045803552 hasConceptScore W2045803552C556039675 @default.
• W2045803552 hasConceptScore W2045803552C71924100 @default.
• W2045803552 hasConceptScore W2045803552C86803240 @default.
• W2045803552 hasConceptScore W2045803552C91375879 @default.
• W2045803552 hasConceptScore W2045803552C99454951 @default.
• W2045803552 hasIssue "10" @default.
• W2045803552 hasLocation W20458035521 @default.
• W2045803552 hasLocation W20458035522 @default.
• W2045803552 hasLocation W20458035523 @default.
• W2045803552 hasLocation W20458035524 @default.
• W2045803552 hasLocation W20458035525 @default.
• W2045803552 hasOpenAccess W2045803552 @default.
• W2045803552 hasPrimaryLocation W20458035521 @default.
• W2045803552 hasRelatedWork W1443123756 @default.
• W2045803552 hasRelatedWork W2071975484 @default.
• W2045803552 hasRelatedWork W2089844138 @default.
• W2045803552 hasRelatedWork W2259132420 @default.
• W2045803552 hasRelatedWork W2402550396 @default.
• W2045803552 hasRelatedWork W2412791743 @default.
• W2045803552 hasRelatedWork W2604399054 @default.

• next